Fenwick & West represented Sierra Oncology, Inc. in the deal. Sierra Oncology, Inc. (NASDAQ: SRRA) issued its underwritten public offering of Series A convertible preferred stock,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
